Acta Med. 2008, 51: 185-190
https://doi.org/10.14712/18059694.2017.22
Monitoring of Serum Levels of Angiogenin, ENA-78 and GRO Chemokines in Patients with Renal Cell Carcinoma (RCC) in the Course of the Treatment
Dagmar Hlávkováa, Otakar Kopecký
b,c, Šárka Lukešová
b,c, Vladimíra Vroblová
a, Ctirad Andrýs
a, Petr Morávek
d, Miroslav Podhola
e, Doris Vokurková
a, Hynek Šafránek
d
aCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Department of Clinical Immunology and Allergology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Oncological Department of District Hospital, Náchod, Czech Republic
cCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, 2nd Department of Internal Medicine, Hradec Králové, Czech Republic
dCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Department of Urology, Hradec Králové, Czech Republic
eCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Fingerland’s Department of Pathology, Hradec Králové, Czech Republic
Received December 1, 2007
Accepted June 1, 2008
Crossref Cited-by Linking
- Kim Eun Ji, Park Heesook, Kim Jongdai, Park Jung Han Yoon: 3,3′‐diindolylmethane suppresses 12‐O‐tetradecanoylphorbol‐13‐acetate‐induced inflammation and tumor promotion in mouse skin via the downregulation of inflammatory mediators. Molecular Carcinogenesis 2010, 49, 672. <https://doi.org/10.1002/mc.20640>
- Jung Jae‐Joon, Noh Sewon, Jeung Hei‐Cheul, Jung Minkyu, Kim Tae Soo, Noh Sung Hoon, Roh Jae Kyung, Chung Hyun Cheol, Rha Sun Young: Chemokine growth‐regulated oncogene 1 as a putative biomarker for gastric cancer progression. Cancer Science 2010, 101, 2200. <https://doi.org/10.1111/j.1349-7006.2010.01666.x>
